Mark S. Shearman, EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. (EDIT), sold 10,290 shares at $10.06 ($104K) on 2022-06-15, disclosed to the SEC on 2022-06-16.
Open-market sale of $104k EDIT by EVP, CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.06 | 5,145 | $52K | 50.0% |
| 2 | $10.06 | 5,145 | $52K | 50.0% |
| Total | $10.06 avg | 10,290 | $104K | 100% |
| Filing → |
| AGTC | BUY | 2016-09-26 | $27K | — | Filing → |